quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:06·381d
SECFiling
Nevro Corp. logo

SEC Form EFFECT filed by Nevro Corp.

NVRO· Nevro Corp.
Health Care
Original source

Companies

  • NVRO
    Nevro Corp.
    Health Care

Recent analyst ratings

  • Feb 10UpdateJefferies$5.85
  • Feb 7UpdatePiper Sandler$5.85
  • Dec 3UpdateWells Fargo$5.00
  • Dec 2UpdateMorgan Stanley$4.00
  • Aug 9UpdateCitigroup-
  • Aug 8UpdateWolfe Research-

Related

  • SEC374d
    SEC Form 15-12G filed by Nevro Corp.
  • SEC384d
    Amendment: SEC Form SCHEDULE 13D/A filed by Nevro Corp.
  • INSIDER385d
    Director Mccormick Shawn returned 46,035 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER385d
    Director Kosaraju Sridhar returned 46,575 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER385d
    Director Grossman D Keith returned 228,552 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER385d
    SVP, Chief Financial Officer Macleod Roderick H. returned 350,663 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER385d
    Director Demane Michael F returned 503,618 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER385d
    Director Karros Kirt P returned 17,452 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022